APUS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Apimeds Pharmaceuticals US Inc (APUS) Moving Averages Convergence Divergence (MACD) indicator is -0.0762, suggesting APUS is Sell.

Apimeds Pharmaceuticals US Inc (APUS) 20-Day simple moving average is 1.319, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it Buy.

Apimeds Pharmaceuticals US Inc (APUS) 60-Day simple moving average is 1.619, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it Sell.

Technical Analysis for APUS

Technical Sentiment Analysis for Apimeds Pharmaceuticals US Inc (APUS) As of 2026-03-11, Apimeds Pharmaceuticals US Inc (APUS) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 4 indicators are flashing buy, while 6 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for APUS stands at 45.81, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.0762, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 32.645 and the Commodity Channel Index (CCI) at 50.477 further confirm a -0.03 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, APUS is trading below its 60-day moving average of $1.619 and below its 200-day long-term moving average of $1.868. Key price levels to watch include the immediate resistance at $1.438 and strong support at $1.238. A break above $1.438 could signal a bull continuation, while falling below $1.238 may test the next Fibonacci floor at $1.144.

Apimeds Pharmaceuticals US Inc (APUS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.038	1.144	1.238	1.344	1.438	1.544	1.638
Fibonacci	1.144	1.22	1.268	1.344	1.42	1.468	1.544

Apimeds Pharmaceuticals US Inc (APUS) Technical Indicators

2026-03-11

Name	Value
RSI_14	45.81
STOCHk_14_3_3	32.645
STOCHd_14_3_3	30.394
CCI_20	50.477
AO_5_34	-0.208
MOM_10	-0.03
MACD_12_26_9	-0.0762

Apimeds Pharmaceuticals US Inc (APUS) Relative Strength Index (RSI) is 45.81, creating a Neutral signal.

Apimeds Pharmaceuticals US Inc (APUS) Stochastic Oscillator is 32.645, creating a Neutral signal.

Apimeds Pharmaceuticals US Inc (APUS) Stochastic RSI is 30.394, creating a Neutral signal.

Apimeds Pharmaceuticals US Inc (APUS) Commodity Channel Index (CCI) is 50.477, creating a Neutral signal.

Apimeds Pharmaceuticals US Inc (APUS) Awesome Oscillator is -0.208, creating a Sell signal.

Apimeds Pharmaceuticals US Inc (APUS) Momentum is -0.03, creating a Sell signal.

Apimeds Pharmaceuticals US Inc (APUS) MACD is -0.0762, creating a Sell signal.

Apimeds Pharmaceuticals US Inc (APUS) Moving Average

2026-03-11

Period	Simple	Signal
MA_5	1.324	Buy
MA_10	1.332	Buy
MA_20	1.319	Buy
MA_60	1.619	Sell
MA_200	1.868	Sell
MA_250	1.876	Sell

Apimeds Pharmaceuticals US Inc (APUS) 5-Day simple moving average is 1.324, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Buy.

Apimeds Pharmaceuticals US Inc (APUS) 10-Day simple moving average is 1.332, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Buy.

Apimeds Pharmaceuticals US Inc (APUS) 20-Day simple moving average is 1.319, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Buy.

Apimeds Pharmaceuticals US Inc (APUS) 60-Day simple moving average is 1.619, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Sell.

Apimeds Pharmaceuticals US Inc (APUS) 200-Day simple moving average is 1.868, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Sell.

Apimeds Pharmaceuticals US Inc (APUS) 250-Day simple moving average is 1.876, while Apimeds Pharmaceuticals US Inc (APUS) share price is $1.34, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for APUS?

The overall technical consensus for Apimeds Pharmaceuticals US Inc (APUS) is currently Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 1 buy signals and 3 sell signals.

What are the key support and resistance levels for Apimeds Pharmaceuticals US Inc (APUS) today?

Based on pivot point calculations, Apimeds Pharmaceuticals US Inc (APUS) has an immediate support level at 1.238 and a major resistance level at 1.438. Traders also monitor the pivot point at 1.344 to determine the intraday trend direction.

Is Apimeds Pharmaceuticals US Inc (APUS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Apimeds Pharmaceuticals US Inc (APUS) is currently 45.81. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Apimeds Pharmaceuticals US Inc (APUS)?

Apimeds Pharmaceuticals US Inc (APUS) Moving Averages Convergence Divergence (MACD) indicator is -0.0762, suggesting APUS is Sell. This indicator helps identify potential trend reversals or momentum shifts for Apimeds Pharmaceuticals US Inc.

How is Apimeds Pharmaceuticals US Inc (APUS) performing relative to its 200-day moving average?

Apimeds Pharmaceuticals US Inc (APUS) is currently trading at $1.34, which is below its 200-day simple moving average of 1.868. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.